Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.
Zhou C, Li X, Wang C, Zhang J.
Clin Rev Allergy Immunol. 2021 Dec;61(3):403-423. doi: 10.1007/s12016-021-08883-0. Epub 2021 Aug 17.
Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis.
Lee HH, Gwillim E, Patel KR, Hua T, Rastogi S, Ibler E, Silverberg JI.
J Am Acad Dermatol. 2020 Mar;82(3):675-682. doi: 10.1016/j.jaad.2019.08.032. Epub 2019 Aug 19.
Janus kinase inhibitors for alopecia areata.
King BA, Craiglow BG.
J Am Acad Dermatol. 2023 Aug;89(2S):S29-S32. doi: 10.1016/j.jaad.2023.05.049.
Pediatric Alopecia Areata.
Afford R, Leung AKC, Lam JM.
Curr Pediatr Rev. 2021;17(1):45-54. doi: 10.2174/1573396316666200430084825.
Alopecia areata: What's new in the epidemiology, comorbidities, and pathogenesis?
Dainichi T, Iwata M, Kaku Y.
J Dermatol Sci. 2023 Dec;112(3):120-127. doi: 10.1016/j.jdermsci.2023.09.008. Epub 2023 Oct 11.
Successful treatment of alopecia universalis with abrocitinib: a case report.
Zhang J, Zuo YG.
J Dermatolog Treat. 2023 Dec;34(1):2242706. doi: 10.1080/09546634.2023.2242706.
Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis.
Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, Shapiro J.
J Am Acad Dermatol. 2018 Jan;78(1):1-12. doi: 10.1016/j.jaad.2017.04.1141.
Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis.
Mesinkovska N, King B, Zhang X, Guttman-Yassky E, Magnolo N, Sinclair R, Mizuashi M, Shapiro J, Peeva E, Banerjee A, Takiya L, Cox LA, Wajsbrot D, Kerkmann U, Law E, Wolk R, Schaefer G.
J Dermatol. 2024 Nov;51(11):1414-1424. doi: 10.1111/1346-8138.17442. Epub 2024 Sep 27.
Tofacitinib in the Management of Alopecia Universalis.
Agarwal P.
Int J Trichology. 2023 Sep-Oct;15(5):194-196. doi: 10.4103/ijt.ijt_77_23. Epub 2024 Jul 11.
Treatments for alopecia areata: a network meta-analysis.
Mateos-Haro M, Novoa-Candia M, Sánchez Vanegas G, Correa-Pérez A, Gaetano Gil A, Fernández-García S, Ortega-Quijano D, Urueña Rodriguez MG, Saceda-Corralo D, Bennouna-Dalero T, Giraldo L, Tomlinson J, Vaño-Galván S, Zamora J.
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013719. doi: 10.1002/14651858.CD013719.pub2.
